Fluorescence in situ hybridization (FISH) is a molecular cytogenetic process which usually uses fluorescent samples that attach with a high degree of sequence complementarity to only those parts of a nucleic acid chain. This approach provides scientists with a new way of visualizing and measuring the genetic material in a single cell, including specific genes or parts of genes. It is an essential way of understanding a wide range of chromosomal and other genetic mutations. They are also used detect specific RNA targets in cells, tissue cells, and circulating tumor cells. Some of the common technologies which are used FISH probe such as DISH, CISH, and FISH. Researchers usually use three different types of FISH probes such as alphoid or centromeric repeat probes, locus specific probes, and whole chromosome probes.
Increase in the cytogenic-based illness, genetic abnormalities including carcinogenesis: Cytogenetics is a genetic division concerned with how the chromosomes contribute to the behavior of the cells, particularly their behavior during mitosis and meiosis. Clinical cytogenetics has a significant impact on the treatment regulation and prevention of many chromosome aberrations-induced disorders. Tumorigenesis is cancer development that turns normal cells into cancer cells. Changes in cell, genetic, and epigenetic levels and abnormal cell division characterize the process
The global flourescent in situ hybridization (fish) probe market is segmented on the basis of technology as FISH, CISH, & DISH; type as DNA, & RNA; application as cancer research, genetic diseases, & other and end user as research, clinical, and companion diagnostics
“According to Data Bridge Market Research, global flourescent in situ hybridization probe market is expected to register a substantial CAGR of 6.6% in the forecast period of 2019-2026”
Few of the major market competitors currently working in the global flourescent in situ hybridization probe market are Oxford Gene Technology, Agilent Technologies Inc, PerkinElmer Inc,, Horizon Discovery Group plc, BioDot, Sysmex Singapore Pte. Ltd, ADS Biotech Inc., Thermo Fisher Scientific, Abnova Corporation, LGC Biosearch Technologies, F. Hoffmann-La Roche Ltd, Biocare Medical,LLC, QIAGEN, Bio-Rad Laboratories, Creative BioMart, MetaSystems, Applied Spectral Imaging, Leica Biosystems Nussloch GmbH, Tocris Bioscience, Empire Genomics, LLC among others.
Increasing chronic diseases and growing demand for IVD due to their high reliability and rapidity of the FISH probe technique will also accelerate the growth. DNA-based diagnostics are becoming increasingly popular in medical diagnostics to establish suspected diseases caused by pathogen or bacteria. Rising genetic disorders such as Acute Lymphoblastic Leukemia will also enhance the market growth. These are some of the factors which are creating new opportunities in the growth and development of this market.
Browse in Healthcare Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/